Company Overview
| Stock Name | Charmacy Phar |
|---|---|
| Stock Code | 02289 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國從事分銷藥品。 |
| Listing Date | 2015-12-14 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省汕頭市龍湖區嵩山北路235號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.chmyy.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 8.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 10.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 72,240,000 |
Stock Connect Inclusion
| HK Market Cap | --- |
|---|
| 26Q2 Regular Review | |
| Inclusion Pathway | None |
|---|---|
| Est. Threshold | --- |
| Analysis Result | 无法确定入通路径 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 8.0 |
|---|---|
| First Day Open | HK$ 7.7 |
| First Day Change | -6.98% |
| First Day Volume | 8018500.0 |
| First Day Turnover | 64439800.0 |
Use of Proceeds
| Use of Proceeds | 1、約64.8百萬港元（約35%）將用于增強、擴展及整合我們現存的分銷網絡及能力； 2、約18.5百萬港元（約10%）將用于改良及推廣我們的B2B電子商務平臺； 3、約55.6百萬港元（約30%）將用于償還銀行借款； 4、約27.8百萬港元（約15%）將用于收購華南地區的醫藥分銷業務； 5、約18.5百萬港元（約10%）用于營運資金及一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
GUOTAI JUNAN CAPITAL LIMITED CE AGS488
Overall Coordinators (1)
GUOTAI JUNAN SECURITIES (HONG KONG) LIMITED CE ABY236
Joint Bookrunners (1)
GUOTAI JUNAN SECURITIES (HONG KONG) LIMITED CE ABY236
Joint Lead Managers (3)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 广药白云山香港有限公司 | 67,995,900 HKD | — | 7.30% | — | 6 months | 2016-06-14 |
| 2 | 香雪集团(香港)有限公司 | 29,996,800 HKD | — | 3.20% | — | 6 months | 2016-06-14 |
Directors & Management
| Chairman | 嚴京斌 |
|---|---|
| Company Secretary | 姚潔晞 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 姚創龍(40.97%);江西江中醫藥商業運營有限責任公司(26.90%) |
|---|
